Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GENESYS.NS Stock Summary
Top 10 Correlated ETFs
GENESYS.NS
In the News
GENESYS.NS Financial details
Company Rating
Neutral
Market Cap
22.33B
Income
93.75M
Revenue
1.74B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1.05K
Optionable
No
Shortable
Yes
Earnings
03 Nov 2023
P/E
1353.2
Forward P/E
-
PEG
-329.07
P/S
11.07
P/B
4.66
P/C
-
P/FCF
695.8
Quick Ratio
1.45
Current Ratio
2.82
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
2.52
EPS next Y
-
EPS next Q
-
EPS this Y
27.1%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
9.56%
Revenue Q/Q
78.79%
EPS Q/Q
-581.61%
-
-
-
-
SMA20
8.3%
SMA50
15.4%
SMA100
78.68%
Inst Own
-
Inst Trans
-
ROA
-
ROE
1%
ROC
0.03%
Gross Margin
42%
Oper. Margin
7%
Profit Margin
1%
Payout
-
Shs Outstand
40.91M
Shs Float
12.19M
-
-
-
-
Target Price
-
52W Range
266.0-666.1
52W High
-11.94%
52W Low
+120.49%
RSI
55.79
Rel Volume
1.44
Avg Volume
317.79K
Volume
457.19K
Perf Week
0.95%
Perf Month
22.54%
Perf Quarter
64.52%
Perf Half Y
63.51%
-
-
-
-
Beta
0.311
-
-
Volatility
15.98%, 39.95%
Prev Close
9.99%
Price
586.5
Change
6.64%
GENESYS.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 37.01 | 33.86 | 25.52 | 34.8 | 51.53 | |
Net income per share | -1.2 | -1.63 | -16.61 | 4.01 | 5.43 | |
Operating cash flow per share | -7.41 | 9.53 | 9.25 | 8.21 | -10.01 | |
Free cash flow per share | -17 | 5.86 | 3.92 | 1.48 | -37.88 | |
Cash per share | 0.75 | 2.19 | 3 | 8.26 | 41.88 | |
Book value per share | 72.21 | 68.36 | 55.59 | 61.18 | 115.35 | |
Tangible book value per share | 42.54 | 42.24 | 28.44 | 33.21 | 71.45 | |
Share holders equity per share | 72.21 | 68.36 | 55.59 | 61.18 | 115.35 | |
Interest debt per share | 9.15 | 5.96 | 5.3 | 8.66 | 11.95 | |
Market cap | 2.98B | 755.24M | 3.24B | 19.12B | 11.56B | |
Enterprise value | 3.22B | 890.38M | 3.36B | 19.17B | 11.83B | |
P/E ratio | -79.75 | -14.85 | -6.25 | 142.57 | 60.58 | |
Price to sales ratio | 2.59 | 0.72 | 4.07 | 16.41 | 6.38 | |
POCF ratio | -12.96 | 2.54 | 11.24 | 69.58 | -32.84 | |
PFCF ratio | -5.65 | 4.14 | 26.54 | 385.98 | -8.68 | |
P/B Ratio | 1.33 | 0.35 | 1.87 | 9.34 | 2.85 | |
PTB ratio | 1.33 | 0.35 | 1.87 | 9.34 | 2.85 | |
EV to sales | 2.81 | 0.84 | 4.23 | 16.45 | 6.53 | |
Enterprise value over EBITDA | 14.63 | 5.28 | -1.94K | 62.41 | 18.14 | |
EV to operating cash flow | -14.04 | 3 | 11.67 | 69.77 | -33.6 | |
EV to free cash flow | -6.12 | 4.88 | 27.56 | 386.99 | -8.88 | |
Earnings yield | -0.01 | -0.07 | -0.16 | 0.01 | 0.02 | |
Free cash flow yield | -0.18 | 0.24 | 0.04 | 0 | -0.12 | |
Debt to equity | 0.12 | 0.08 | 0.08 | 0.13 | 0.1 | |
Debt to assets | 0.07 | 0.04 | 0.04 | 0.08 | 0.08 | |
Net debt to EBITDA | 1.12 | 0.8 | -71.82 | 0.16 | 0.41 | |
Current ratio | 2.17 | 2.75 | 2.13 | 1.73 | 3.52 | |
Interest coverage | 0 | -3.07 | -6.47 | 3.38 | 7.94 | |
Income quality | -61.98 | -4.48 | -0.53 | -0.77 | -1.41 | |
Dividend Yield | 0 | 0.01 | 0 | 0 | 0 | |
Payout ratio | -0.13 | -0.09 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0.03 | 0.04 | 0.03 | 0.05 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.48 | 0.48 | 0.55 | 0.39 | 0.31 | |
Capex to operating cash flow | 1.3 | -0.39 | -0.58 | -0.82 | 2.78 | |
Capex to revenue | -0.26 | -0.11 | -0.21 | -0.19 | -0.54 | |
Capex to depreciation | -1.59 | -0.54 | -0.89 | -1.18 | -2.61 | |
Stock based compensation to revenue | 0.02 | -0.04 | 0 | 0.01 | 0.01 | |
Graham number | 44.23 | 50.12 | 144.14 | 74.26 | 118.69 | |
ROIC | 0 | -0.03 | -0.09 | 0.04 | 0.03 | |
Return on tangible assets | -0.02 | -0.03 | -0.38 | 0.07 | 0.05 | |
Graham Net | 8.14 | 2.45 | -0.12 | 2.56 | 40.42 | |
Working capital | 719.6M | 769.28M | 416.68M | 547.81M | 1.74B | |
Tangible asset value | 1.32B | 1.32B | 886.54M | 1.11B | 2.51B | |
Net current asset value | 656.13M | 623.06M | 292.44M | 446.86M | 1.45B | |
Invested capital | 0.12 | 0.08 | 0.08 | 0.13 | 0.1 | |
Average receivables | 497.74M | 908.75M | 701.25M | 752.97M | 1.25B | |
Average payables | 124.08M | 157.18M | 143.15M | 193.89M | 242.78M | |
Average inventory | 160.55M | 138.89M | -62.52M | -70.86M | -285.7M | |
Days sales outstanding | 316.7 | 284.54 | 266.31 | 289.93 | 318.64 | |
Days payables outstanding | 72.76 | 73.91 | 72.54 | 119.13 | 78.47 | |
Days of inventory on hand | 153.17 | -19.79 | -47.61 | -27.15 | -180.54 | |
Receivables turnover | 1.15 | 1.28 | 1.37 | 1.26 | 1.15 | |
Payables turnover | 5.02 | 4.94 | 5.03 | 3.06 | 4.65 | |
Inventory turnover | 2.38 | -18.44 | -7.67 | -13.45 | -2.02 | |
ROE | -0.02 | -0.02 | -0.3 | 0.07 | 0.05 | |
Capex per share | -9.6 | -3.67 | -5.33 | -6.73 | -27.87 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 15.58 | 13.57 | 9.15 | 8.78 | 15.76 | |
Net income per share | 2.25 | 0.63 | -1.41 | -0.87 | 4.21 | |
Operating cash flow per share | 5.33 | 0.78 | 5.98 | 5.79 | 5.87 | |
Free cash flow per share | 5.33 | 0.78 | 5.98 | 5.79 | 5.87 | |
Cash per share | 26.81 | 42.83 | 18.3 | 28.22 | 0 | |
Book value per share | 110.74 | 117.97 | 107.87 | 105.94 | 0 | |
Tangible book value per share | 0 | 73.07 | 0 | 58.68 | 0 | |
Share holders equity per share | 110.74 | 117.97 | 107.87 | 105.94 | 0 | |
Interest debt per share | 0.1 | 11.8 | 0.18 | 9.56 | 0.29 | |
Market cap | 15.88B | 11.3B | 11.84B | 13.34B | 16.22B | |
Enterprise value | 16.82B | 11.57B | 12.53B | 13.66B | 16.22B | |
P/E ratio | 50.52 | 131.26 | -55.52 | -100.98 | 25.58 | |
Price to sales ratio | 29.18 | 24.24 | 34.27 | 40.19 | 27.34 | |
POCF ratio | 85.36 | 420.72 | 52.38 | 60.96 | 73.35 | |
PFCF ratio | 85.36 | 420.72 | 52.38 | 60.96 | 73.35 | |
P/B Ratio | 4.11 | 2.79 | 2.91 | 3.33 | 0 | |
PTB ratio | 4.11 | 2.79 | 2.91 | 3.33 | 0 | |
EV to sales | 30.9 | 24.81 | 36.27 | 41.17 | 27.34 | |
Enterprise value over EBITDA | 79.54 | 65.26 | 186.2 | 155 | 52.72 | |
EV to operating cash flow | 90.39 | 430.68 | 55.44 | 62.45 | 73.35 | |
EV to free cash flow | 90.39 | 430.68 | 55.44 | 62.45 | 73.35 | |
Earnings yield | 0 | 0 | 0 | 0 | 0.01 | |
Free cash flow yield | 0.01 | 0 | 0.02 | 0.02 | 0.01 | |
Debt to equity | 0 | 0.1 | 0 | 0.09 | 0 | |
Debt to assets | 0 | 0.08 | 0 | 0.07 | 0 | |
Net debt to EBITDA | 4.43 | 1.51 | 10.27 | 3.7 | 0 | |
Current ratio | 0 | 3.52 | 0 | 2.82 | 0 | |
Interest coverage | 33.71 | 5.63 | -8.26 | -2.94 | 18.12 | |
Income quality | 2.37 | 1.25 | -4.24 | -6.63 | 1.39 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.31 | 0 | 0.36 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0.06 | 0 | 0 | 0 | |
Graham number | 74.88 | 40.77 | 58.52 | 45.63 | 0 | |
ROIC | 0.02 | 0.01 | -0.01 | -0.01 | 0 | |
Return on tangible assets | 0 | 0.01 | 0 | -0.01 | 0 | |
Graham Net | 26.81 | 41.34 | 18.3 | 18.31 | 0 | |
Working capital | 936.52M | 1.74B | 691.35M | 1.34B | 0 | |
Tangible asset value | 0 | 2.51B | 0 | 2.22B | 0 | |
Net current asset value | 936.52M | 1.45B | 691.35M | 1.04B | 0 | |
Invested capital | 0 | 0.1 | 0 | 0.09 | 0 | |
Average receivables | 323M | 790.61M | 790.61M | 443.09M | 443.09M | |
Average payables | 137M | 111.14M | 111.14M | 148.55M | 148.55M | |
Average inventory | 325.5K | -255.71M | -255.71M | 0 | 0 | |
Days sales outstanding | 0 | 305.23 | 0 | 240.32 | 0 | |
Days payables outstanding | 0 | 71.68 | 0 | 127.97 | 0 | |
Days of inventory on hand | 0 | -164.93 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0.29 | 0 | 0.37 | 0 | |
Payables turnover | 0 | 1.26 | 0 | 0.7 | 0 | |
Inventory turnover | 0 | -0.55 | 0 | 0 | 0 | |
ROE | 0.02 | 0.01 | -0.01 | -0.01 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
GENESYS.NS Frequently Asked Questions
What is Genesys International Corporation Limited stock symbol ?
Genesys International Corporation Limited is a IN stock and trading under the symbol GENESYS.NS
What is Genesys International Corporation Limited stock quote today ?
Genesys International Corporation Limited stock price is $586.5 today.
Is Genesys International Corporation Limited stock public?
Yes, Genesys International Corporation Limited is a publicly traded company.